Healthcare & Life Sciences
Syntis Bio
United Statessyntis.bio
Syntis Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Syntis Bio
Syntis Bio is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Syntis Bio develops oral therapies targeting the small intestine to treat metabolic health conditions including obesity, diabetes, and rare genetic diseases by leveraging the small intestine’s unique biology.
Explore Syntis Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.